Since early study indicated that PTEN and BTG2 were canonical downregulated by miR‐21 overexpression in myeloma cells (Leone et al., 2013), we further demonstrated that PTEN also stimulated BTG2 in human bladder cancer. The gene discussed is BTG2; the disease is urinary bladder cancer.